Search Results - "Mahé, M.A"

PO-0686: Locoregional failure in locally advanced non-small cell lung cancer after definitive radiotherapy by Jouglar, E, Isnardi, V, Goulon, D, Ségura-Ferlay, C, Ayadi, M, Dupuy, C, Mahé, M.A, Claude, L

Get full text

Sarcoma in irradiated area (SARI): radiation-induced CD8 T-lymphocytes apoptosis as a potential predisposition factor: results of the SARI trial by Maingon, P, Mirjolet, C, Truc, G, Karine, P.C, Nöel, G, Thariat, J, Le Pechoux, C, Sargos, P, Marchal, C, Blay, J.Y, Salas, S, Delannes, M, Lagrange, J.L, Mahé, M.A, Coindre, J.M, Collin, F, Chibon, F, Grisi, C, Gauthier, M, Merlin, J.L

Get full text

EP-1398: Acute gastro-intestinal toxicities after pre-operative tomotherapy for retroperitoneal liposarcoma by Sargos, P, Henriques de Figueiredo, B, Kintzinger, C, Stoeckle, E, Delannes, M, Ferron, G, Giraud, A, Dupouy, C, Mahé, M.A, Mervoyer, A, Antoine, M, Bui, B.N, Bellera, C, Kantor, G

Get full text

OC-0145: Preoperative radiotherapy with an integrated boost compared to chemoradiotherapy for rectal cancer by De Ridder, M, De Paoli, A, Delmastro, E, Munoz, F, Vagge, S, Norkus, D, Everaert, H, Tabaro, G, Garibaldi, E, Ricardi, U, Borsatti, E, Gevaert, T, Gabriele, P, Boz, G, Sermeus, A, Mahé, M.A, Engels, B

Get full text

French Multicentric Clinical Evaluation of Helicoidal Tomotherapy for Anal Cancer in a Cohort of 69 Consecutive Patients by Vendrely, V, Rio, E, Henriques, B, Benech, J, Lisbona, A, Belhomme, S, Maire, J.P, Mahé, M.A, Kantor, G

Get full text

A Cost-Analysis of Stereotactic Radiotherapy in Lung Cancer by Perrier, L, Morelle, M, Pommier, P, Plommet, N, Beckendorf, V, Mahé, M.A, Lartigau, E, Boisselier, P, Bondiau, P.Y, Touboul, E, Peignaux Casasnovas, K, Gassa, F, Dussart, S, Claude, L

Get full text

Feasibility study of total marrow irradiation using helical tomotherapy by Chea, M, Llagostera, C, Meyer, P, Cristina, K, Itti, R, Culot, F, De Marzi, L, Cuenca, X, Mahé, M.A, Mazeron, J.J, Lisbona, A, Jenny, C

“…Introduction The clinical investigation project TOMMY suggests an alternative study to Total Body Irradiation (TBI): Total Marrow Irradiation (TMI) which…”
Get full text

2010 Prospective evaluation of lung radiation acute toxicity in non small cell lung cancer (NSCLC): impact of the timing by Dussart, S, Mahé, M.A, Servois, V, Arpin, D, Helfre, S, Prevost, B, Carrie, C, Claude, L

Get full text

High Dose Hypofractionated Stereotactic Body Radiation Therapy of Non Compressive Vertebral Bone Metastases in Combination With Zoledronic Acid: A Phase 1 Study by Pichon, B, Mahe, M.A, Delpon, G, Thillays, F, Carrie, C, Cellier, P, Pommier, P, Laude, C, Mervoyer, A, Supiot, S

Get full text

Preoperative Tomotherapy for Retroperitoneal Liposarcoma: Analysis of Acute Gastrointestinal Toxicities From a Phase 2 Prospective Multicenter Study by Kantor, G, Henriques, B, Kintzinger, C, Stoeckle, E, Delannes, M, Ferron, G, Giraud, A, Dupouy, C, Picaud, F, Mahe, M.A, Mervoyer, A, Antoine, M, Bui, B.N, Bellera, C, Sargos, P

Get full text

PO-1465 5-year survival and toxicity results of SIB radiotherapy in (very) high-risk prostate cancer by Masson, I., Guerin-Charbonnel, C., Azria, D., Pommier, P., Mesgouez-Nebout, N., Giraud, P., Peiffert, D., Chauvet, B., Dudouet, P., Salem, N., Noel, G., Khalifa, J., Latorzeff, I., Mahé, M.A., Supiot, S.

Get full text

EP-1129 QUALITY OF LIFE 54 MONTHS AFTER HIGH-DOSE INTENSITY-MODULATED RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER by Goineau, A, Marchand, V, Bourdin, S, Rio, E, Campion, L, Lisbona, A, Mahe, M.A, Supiot, S

Get full text

Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30 years of life: A French multicentre cohort study by Demoor-Goldschmidt, C., Supiot, S., Oberlin, O., Helfre, S., Vigneron, C., Brillaud-Meflah, V., Bernier, V., Laprie, A., Ducassou, A., Claude, L., Mahé, M.A., de Vathaire, F.

Get full text

1572 - Sarcoma in irradiated area (SARI): radiation-induced CD8 T-lymphocytes apoptosis as a potential predisposition factor: results of the SARI trial by Maingon, P., Mirjolet, C., Truc, G., Karine, P.C., Nöel, G., Thariat, J., Le Pechoux, C., Sargos, P., Marchal, C., Blay, J.Y., Salas, S., Delannes, M., Lagrange, J.L., Mahé, M.A., Coindre, J.M., Collin, F., Chibon, F., Grisi, C., Gauthier, M., Merlin, J.L.

Get full text

Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study by Demoor-Goldschmidt, C., Supiot, S., Oberlin, O., Helfre, S., Vigneron, C., Brillaud-Meflah, V., Bernier, V., Laprie, A., Ducassou, A., Claude, L., Mahé, M.A., de Vathaire, F.

“…Irradiation (>3Gy) to the breast or axillae before 30years of age increases the risk of secondary breast cancer (SBC). The purpose of this article is to…”
Get full text

423 Quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer by Goineau, A, Marchand, V, Bourdin, S, Rio, E, Campion, L, Lisbona, A, Mahé, M.A, Supiot, S

Get full text

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort studyResearch in context by C. Mirjolet, J.L. Merlin, G. Truc, G. Noël, J. Thariat, J. Domont, P. Sargos, S. Renard-Oldrini, I. Ray-Coquard, X. Liem, C. Chevreau, J.L. Lagrange, M.A. Mahé, F. Collin, F. Bonnetain, A. Bertaut, P. Maingon

“…Purpose: Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discussed during the implementation of new radiation techniques…”
Get full text

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study by Mirjolet, C., Merlin, J.L., Truc, G., Noël, G., Thariat, J., Domont, J., Sargos, P., Renard-Oldrini, S., Ray-Coquard, I., Liem, X., Chevreau, C., Lagrange, J.L., Mahé, M.A., Collin, F., Bonnetain, F., Bertaut, A., Maingon, P.

“…Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discussed during the implementation of new radiation techniques and…”
Get full text

Radiothérapie des lymphomes malins non hodgkiniens ganglionnaires folliculaires et diffus de stade limité by Demoor-Goldschmidt, C., Agape, P., Barillot, I., Mahé, M.A.

“…L’utilisation croissante des anticorps monoclonaux et notamment du rituximab est susceptible de faire évoluer la place de la radiothérapie dans les lymphomes…”
Get full text

Radiothérapie des lymphomes by Barillot, I., Mahé, M.A., Antoni, D., Hennequin, C.

“…La radiothérapie des lymphomes hodgkinien a évolué au cours du temps, mais garde une place prépondérante lors de la prise en charge des tumeurs de stade…”
Get full text